RecruitingPhase 3NCT07484217
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Sponsor: Axsome Therapeutics, Inc.
Tucson, AZ · Bellflower, CA · Chino, CA · +37 more sites
Phase 3 Depression clinical trials
11 recruiting Phase 3 depression studies in the US. What trial phases mean
Other phases
RecruitingPhase 3NCT07775300
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Sponsor: Eli Lilly and Company
Birmingham, AL · Phoenix, AZ · Irvine, CA · +31 more sites
RecruitingPhase 3NCT06559306
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Sponsor: Janssen Research & Development, LLC
Birmingham, AL · Chandler, AZ · Tucson, AZ · +81 more sites
RecruitingPhase 3NCT07226232
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Sponsor: VA Office of Research and Development
Birmingham, AL · Tuscaloosa, AL · Portland, OR · +2 more sites
RecruitingPhase 3NCT06247839
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Sponsor: Sharmin Ghaznavi
Charlestown, MA
RecruitingPhase 3NCT06963021
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Sponsor: Neurocrine Biosciences
Chino, CA · Los Angeles, CA · Stanford, CA · +12 more sites
RecruitingPhase 3NCT06748222
E-Mindfulness Approaches for Living After Breast Cancer
Sponsor: NRG Oncology
Phoenix, AZ · Fort Smith, AR · Jonesboro, AR · +378 more sites
RecruitingPhase 3NCT04777357
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Sponsor: AbbVie
Bentonville, AR · Anaheim, CA · Beverly Hills, CA · +66 more sites
RecruitingPhase 3NCT07196501
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Sponsor: Neurocrine Biosciences
Oceanside, CA · Orange, CA · San Jose, CA · +21 more sites
RecruitingPhase 3NCT07263022
Cognitive Strategies in Early Psychosis 2
Sponsor: University of Minnesota
Minneapolis, MN
Not yet recruitingPhase 3NCT06835504
Morphine or Ketamine for Analgesia
Sponsor: Columbia University
Los Angeles, CA · Sacramento, CA · Wilmington, DE · +5 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.